Ayr Wellness: Doing Very Well
Ayr Wellness forecast revenues soaring over 54% sequentially to $90 million. The small MSO will quickly rival the size of global cannabis stocks with market valuations in excess of $10 billion. The stock trades at only 7x EV/2022 EBITDA target of $300 million. This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Learn More » The cannabis space has taken a pause since a big rally that peaked in February based on the election of Joe Biden in the U.S Presidential election. With or without the Democrats now in charge pushing for federal legalization of cannabis, Ayr Wellness ( OTCQX:AYRWF ) continues to benefit by a slow approval process leaving most firms stuck on the sidelines. My investment thesis remains very bullish on the stock trading around $30 and valued at about half the EBITDA multiples of the sector. Read the full article on Seeking Alpha. Disclosure: No position mentioned. Please re...